Related Experiment Videos
[Iliac PTA: long-term results and current prospects]
U Bonelli1, R Cerruti, F Baglietto
1Divisione di Chirurgia Vascolare, V USL Finalese, Regione Liguria, Ospedale Santa Corona-Pietra Ligure Savona.
Minerva Chirurgica
|January 1, 1995
Summary
Percutaneous transluminal angioplasty (PTA) is a safe treatment for iliac artery lesions. Results are best for the common iliac artery, but restenosis increases distally, suggesting future use of stents.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Segmentary lesions in the iliac artery are a common vascular condition.
- Treatment options for iliac artery disease aim to restore blood flow and prevent complications.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneous transluminal angioplasty (PTA) for treating segmentary iliac artery lesions.
- To analyze factors influencing restenosis rates after PTA in different segments of the iliac artery.
Main Methods:
- Retrospective analysis of 93 patients who underwent PTA for iliac artery lesions.
- Procedural success rates and complication data were recorded.
- Life table analysis was used to assess restenosis rates over time.
Main Results:
- Successful PTA completion in 85 out of 93 patients.
- Stenosis was the predominant finding (81 cases), often associated with femoro-popliteal occlusion (35 cases).
- Optimal treatment outcomes were observed for the common iliac artery, with increasing restenosis rates in more distal segments.
Conclusions:
- PTA is a safe endovascular procedure for iliac artery stenosis.
- Restenosis rates are segment-dependent, being lower in the common iliac artery.
- Adjunctive endovascular techniques, such as stenting, may be necessary to improve outcomes, particularly for external iliac artery lesions.